Clinical TrialsSearch results
Number of results: 853
Recruiting
- Phase II Study of AM80 and Pembrolizumab in Pancreatic Cancer Patients with Late-Line Therapy
- pancreatic cancer
- Kawashima Hiroki
- 2024-04-01
Recruiting
- Phase II clinical trials aiming to establish standard therapy by chemotherapy for transient myelodysplastic syndrome (TAM)
- Transient abnormal myelopoiesis
- Muramatsu Hideki
- 2019-08-28
Recruiting
- Phase Ib/II Study of the Combination of Tucidinostat and Rituximab in Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
- B-cell Non-Hodgkin's Lymphoma
- Hatake Kiyohiko
- 2022-01-19
Recruiting
- Phase I/IIa clinical study of PAL-222 targeting patients with myopic chorioretinal atrophy
- Myopic chorioretinal atrophy
- Kusano Hitoshi
- 2022-12-16
Recruiting
- Phase 3 Study of Adjuvant V940 and Pembrolizumab in Resected Melanoma
- Malignant Melanoma
- Koh Yasuhiro
- 2024-03-13
Recruiting
- Phase 1b/2 Study of DS-7011a in Patients with Systemic Lupus Erythematosus (SLE)
- Systemic Lupus Erythematosus (SLE)
- Inoguchi Akihiro
- 2024-01-23
Recruiting
- Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
- Mature B-cell lymphomas
- Yamagishi Chika
- 2022-10-04
Recruiting
- Pemigatinib therapy for patients with solid tumors previously treated with FGF-R inhibitor
- advanced solid tumors with FGF-R1 or FGF-R2 amplification FGF-R3 mutation or other FGF-R alteration
- Ando Yuichi
- 2023-11-16
Recruiting
- OptimalCare Study
- Stable angina
- Kinoshita Yoshihisa
- 2023-06-25
Recruiting
- Open-label, Phase 3 Study to Evaluate Efficacy and Safety of Odevixibat (A4250) in Patients with Alagille Syndrome
- Alagille Syndrome
- Achiwa Hiroyuki
- 2024-05-29